UE LifeSciences: Financial Breakdown
Decoding financial health metrics of UE LifeSciences
Total Revenue₹2.8 Cr-31%Prev. FY
Total Expenses₹2.9 Cr-49%Prev. FY
Profit After Tax₹-11.0 Lakh93%Prev. FY
Total Assets₹3.4 Cr-7%Prev. FY
Net Profit Margin-4.0%90%Prev. FY
FAQs on Financials of UE LifeSciences
Yes. In FY25, UE LifeSciences reported a profit after tax of ₹12.9 Lakh, making it profitable.
UE LifeSciences's revenue grew 25.9% year-on-year, from ₹11.8 Cr in FY24 to ₹14.8 Cr in FY25.
UE LifeSciences's estimated EBITDA for FY25 was ₹24.8 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, UE LifeSciences posted revenue of ₹14.8 Cr (up 25.9% YoY) and a profit after tax of ₹12.9 Lakh. Explore the full financials of UE LifeSciences here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links